Join
Live feed
·
INSIDERFilingvia Quantisnow
Telomir Pharmaceuticals Inc. logo

Aminov Erez decreased direct ownership by 0.67% to 29,600 units (SEC Form 5)

ByQuantisnow·Wall Street's wire, on your screen.
TELO· Telomir Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TELO (Telomir Pharmaceuticals Inc.) and more on Quantisnow.

Aminov Erez decreased direct ownership by 0.67% to 29,600 units (SEC Form 5) | Quantisnow